Rubicon Research IPO Sees Exceptional Demand, Subscribed 109.35x by Day 3

Rubicon Research Limited's initial public offering (IPO) has demonstrated exceptional investor interest through its third day of subscription. The stock price band is set at ₹461-485 per share. The ₹1,377.50 crore IPO reached 109.35 times by 5:04:39 PM on day three.

Invest in Indian Markets and Unlock Future Potential With 5paisa!

Open Account Now

Rubicon Research IPO qualified institutional buyers (ex-anchor) segment leads with an exceptional 137.09 times subscription. Non-institutional investors demonstrate exceptional participation at 102.70 times. Retail investors show exceptional interest at 37.40 times. Employees displayed participation at 17.68 times, reflecting robust investor confidence in this company.

Subscription Status of Rubicon Research IPO - Day 1 to Day 3

Subscription Details - Day 3 (October 13, 2025, 5:04:39 PM)

Key Highlights - Day 3

• Overall subscription reached an exceptional 109.35 times, improving from day two's 2.49 times.
• Qualified institutional buyers (ex-anchor) displayed exceptional interest at 137.09 times, rising from 2.22 times on day two.
• Retail investors showed exceptional confidence at 37.40 times, up from 4.16 times on day two.
• Employees performed strongly at 17.68 times, compared to 2.33 times on day two.
• Total applications reached 31,42,203, reflecting exceptional participation for this mainboard IPO.
• Cumulative bid amount reached ₹82,929.00 crores, far exceeding the issue size of ₹1,377.50 crores.

Rubicon Research IPO - Day 2 Subscription at 2.49 Times

Key Highlights - Day 2:

• Overall subscription reached a moderate 2.49 times, showing exceptional improvement from day one's 0.54 times
• Retail investors category displaying strong interest at 4.16 times, building substantially from day one's 1.43 times
• Employees showing moderate performance at 2.33 times, building substantially from day one's 0.97 times
• Qualified institutional buyers (ex-anchor) showing moderate growth at 2.22 times, building substantially from day one's 0.27 times

Rubicon Research IPO - Day 1 Subscription at 0.54 Times

Key Highlights - Day 1:

• Overall subscription reached a limited 0.54 times, showing cautious initial investor interest
• Retail investors are displaying moderate confidence at 1.43 times, showing positive retail sentiment
• Employees showing limited performance at 0.97 times, indicating measured employee sentiment
• Qualified institutional buyers (ex-anchor) showing limited performance at 0.27 times, indicating weak institutional appetite

About Rubicon Research Limited

Incorporated in 1999, Rubicon Research Limited is a pharmaceutical company engaged in the development, manufacturing, and commercialisation of differentiated formulations. As of June 30, 2025, the company has a portfolio of 72 active Abbreviated New Drug Application (ANDA) and New Drug Application (NDA) products approved by the U.S. FDA, including 66 commercialised products.